Diabetes in pregnancy: management from preconception to the postnatal period - Managing type 1 diabetes (T1D) using hybrid closed loops (update)

You can now review and comment on this draft guideline.

The consultation closes on Tuesday 16 June 2026 at 17:00pm.

How to comment

1. Register your organisation or comment as an individual

If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder.

Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.

We can accept comments from individuals. These will be considered, but you won’t get a formal response and they won’t be posted on the NICE website. Wherever possible we encourage you to submit your comments through a registered stakeholder organisation.

2. Read the consultation documents

Documents to comment on:

• Draft guideline
• Evidence review B
• Equality and health inequalities assessment 4
• Methods
• Evidence review B - Appendices
• Acknowledgements

Other information about the consultation

• Committee membership list
• DOI register
• Developing NICE guidelines: how to get involved
• Final scope – for information

3. Add your comments

• You must use this comments form
• You must declare any links with, or funding from, the tobacco industry

If you share similar views with another organisation, send a joint response.

Make sure you consider:

• The areas that will have the biggest impact on practice and be challenging to implement
• How to help users overcome challenges
• Developing NICE guidelines: how to get involved suggests some other areas to comment on.
• As part of the guideline update, we are revising NICE’s quality standard on diabetes in pregnancy (QS109).We propose replacing the current quality statement 3 on continuous glucose monitoring with a quality statement on pregnancy-specific hybrid closed loop systems based on new draft recommendations. We invite you to provide feedback on the draft quality statement below as part of this guideline consultation:
  • Women, trans men and non-binary people who have type 1 diabetes and are pregnant are provided with a pregnancy-specific hybrid closed loop system for managing their glucose levels.

Current quality statements 1, 2, 4 and 5 will have minor amendments, if necessary, in line with updates to the guideline.

4. Email the form to us

Email: diabetesinpregnancy@nice.org.uk

Deadline: 16/06/2026 at 17:00pm